Healthtech Startups

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.

5 investors

Eternal is a personalized health platform that combines wearable data, lab results, and AI coaching to deliver customized podcasts, daily texts, and in-person care for fitness, health, and longevity. The service integrates diagnostics, training, and professional medical oversight for consumers seeking comprehensive health optimization.

5 investors

Euphrates Vascular develops the Pulse NanoMED System, a nanoscale interventional medical device that uses magnetically guided iron-oxide nanoparticles to reach and disrupt distal vascular occlusions beyond the reach of wires and catheters. The technology targets complex vascular occlusions, including stroke, for interventional and vascular treatment.

5 investors

Evaro provides a white-label healthcare platform that lets consumer brands and healthcare companies add prescription treatment services, handling clinical consultations, prescription fulfilment, aftercare, and regulatory compliance. It covers treatment categories such as travel health, sexual wellness, weight management, and mental health, operating an in-house pharmacy and logistics network across the UK.

5 investors

eVisit provides a virtual care platform that helps commercial and public healthcare delivery systems coordinate and deliver care for care teams, patients, service members, veterans, and their families. It aims to expand care access, increase throughput, and reduce costs for hospitals and health systems across the United States.

5 investors

Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases. The company develops novel biologics and a pipeline of engineered proteins aimed at clinical use.

5 investors

EVQLV develops a computational platform for antibody discovery that uses machine learning and computational biology to accelerate and reduce the cost of generating fully-human antibodies for drug development. The platform serves pharmaceutical and biotech partners working on antibody therapeutics.

5 investors

Exact Imaging develops the ExactVu micro-ultrasound platform, a 29 MHz imaging system that lets urologists perform real-time targeted and systematic prostate biopsies within a standard workflow. The platform supports both high-resolution and conventional transducers for prostate, abdominal, and testicular imaging, and serves clinical urology in the EU, US, and Canada.

5 investors

Exer.ai is an artificial intelligence company that helps organizations and individuals optimize performance across technical systems, workforce capabilities, and personal development.

5 investors

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors. It develops cell therapies aimed at cancer treatment by mining the TCR sequence space to identify safe, non-cross-reactive receptors against shared tumor targets.

5 investors

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema. The drug is set to enter Phase IIb clinical trials in 2026.

5 investors

Family First is a Boston-based caregiving benefit that pairs employees with clinically trained Care Experts and a care-coordination platform.

5 investors

Feel Therapeutics develops digital biomarkers and digital health solutions for mental health treatment, designed to function as standalone programs or alongside medications. The company operates within the digital precision medicine space and partners with pharmaceutical and biotech firms on clinical development and commercialization.

5 investors

FICUS builds an AI-supported rehabilitation platform that reduces administrative work for German rehab clinics through connected documentation across all phases of patient care. It targets rehabilitation clinics and treatment teams facing staff shortages and administrative burden.

5 investors

Fig is an app that helps users with dietary restrictions (gluten-free, food intolerances, ingredient avoidance) discover foods and products that match their dietary needs. The platform combines a personalized food fingerprint tool with product matching and community resources to support people navigating food choices.

5 investors

Rescue.co operates an emergency response platform connecting people in urgent need with medical, security, and roadside assistance across East Africa. The company coordinates ground ambulances, helicopters, fixed-wing aircraft, and security providers to deliver rapid emergency care and assistance to corporate members, travelers, and families.

5 investors

Flint connects international and U.S.-based healthcare professionals with hospitals and care organizations offering direct employment and pathways to permanent residency, addressing the critical shortage of nurses in the United States. The company provides end-to-end support including matching, licensing guidance, immigration sponsorship, and relocation services.

5 investors

Flow develops technology-based mental health solutions to address depression symptoms and wellness. The company serves individuals seeking mental health treatment through science-backed approaches.

5 investors

Form Health is a medical weight loss solution that combines medical expertise with patient support to help individuals achieve weight loss and improve overall health.

5 investors

Fountain Life is a private preventive health membership service that uses AI-guided diagnostics, physician-led interpretation, and restorative therapeutics to detect issues early and create personalized plans focused on healthspan and longevity. It offers members always-on access to an integrated care team and an AI medical expert platform (Zori), delivered through clinics located across the United States.

5 investors

Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms. The company serves patients and the physician community seeking alternatives to lifelong pharmaceutical treatments.

5 investors

Fullscript is a clinical platform for healthcare providers to manage supplements, lab ordering, personalized care plans, and patient adherence within their existing EHR workflows. It includes a HIPAA-compliant AI assistant that drafts patient plans, a vetted supplement catalog with third-party testing, and patient engagement tools, serving solo practices through large health systems.

5 investors

Functional Fluidics is a CLIA-certified diagnostic lab offering proprietary red blood cell function biomarker assays, starting with Sickle Cell Disease. It provides contract research services and biomarker testing to clinical providers, pharmaceutical, biotech, and academic partners to support drug development and patient care, with operations in the US and Sub-Saharan Africa.

5 investors

FutureClinic provides direct messaging access to licensed U.S. doctors for ongoing personal healthcare at a fixed monthly subscription price, with AI-assisted intake to reduce administrative burden and ensure unbiased medical advice. The platform connects patients with doctors across 40+ specialties in 28 states and Washington, D.C.

5 investors